Xcout Intel
Atalanta Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Atalanta Therapeutics among biotechnology companies — ranked by similarity to what Atalanta Therapeutics actually does, not by market-cap band.
Subscribe to see Atalanta Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, focused on developing RNA-interference therapeutic interventions for neurodegenerative diseases. The company launched with significant venture backing from life sciences investors.
Atalanta Therapeutics at a glance
Atalanta Therapeutics is a biotechnology company headquartered in United States. It has raised at least $207M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $97M in January 2025. Xcout tracks 5 named people at Atalanta Therapeutics, including Alicia Secor (Former CEO).
Atalanta Therapeutics leadership
- Alicia SecorFormer CEO
- Joanne KotzChief Executive Officer
- Doug PagánChief Financial Officer & Chief Operating Officer
- Alicia Secorfounder
- Stephen KnightPresident and Senior Managing Partner of F-Prime and a member of the Atalanta Board of Directors
Atalanta Therapeutics funding rounds
At least $207M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $97M | 9 named | |
| Series A | $110M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Atalanta Therapeutics competitors
Ranked by semantic similarity — how close each company is to Atalanta Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
City Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in Cambridge, Massachusetts, leading the future of RNA interference therapeutics. The company announced its launch with a $135 million Series A financing and has established strategic research collaborations with partners like Biogen.
Similar biotechnology company
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Similar biotechnology company
Rgenta Therapeutics, Inc. is a biotechnology research company headquartered in Woburn, Massachusetts, that focuses on unlocking the therapeutic potential of disease-relevant RNA targets.
Similar biotechnology company
Argo Therapeutics is a Swiss biotechnology company headquartered in Allschwil, Switzerland, focused on neurodegenerative-disease therapeutics.
Similar biotechnology company
Harness Therapeutics Ltd. is a biotechnology company founded in 2023 and based in Cambridge, United Kingdom. The company focuses on RNA biology and the development of novel therapeutics for the treatment of neurodegenerative diseases.
Life Sciences
AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company founded in 2011 and headquartered in Boston, Massachusetts. The company focuses on developing novel treatments for devastating neurological conditions.
Similar biotechnology company
Falcon Bio is a drug discovery company headquartered in Boston, Massachusetts, focused on targeting the root cause of cellular dysfunction to treat Friedreich's ataxia patients.
Similar biotechnology company
Vigil Neuroscience is a biotechnology company headquartered in Massachusetts that harnesses the power of microglia for the treatment of neurodegenerative diseases.
Similar biotechnology company
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Biotech
Manifold Biotechnologies, Inc. develops biotechnology solutions for biologic drug discovery and development, specializing in molecular tracking and high-throughput in vivo screening. The company builds an AI-guided direct-to-vivo discovery platform designed to accelerate the development of tissue-targeted medicines, including RNA interference treatments for neurological diseases.
Similar biotechnology company
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Similar biotechnology company
Delix Therapeutics is a privately held biopharmaceutical company headquartered in Boston, Massachusetts, focused on transforming the treatment of brain health through neuroscience.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Atalanta Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Atalanta Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →